ReviewJournal of cancer research and clinical oncology2019

Preclinical rationale and clinical efficacy of antiangiogenic therapy and immune checkpoint blockade combination therapy in urogenital tumors.

Ning Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.